Account
Dentsu Aegis Network wins Maruti Suzuki’s digital mandate
MUMBAI: Following a multi-agency pitch, Dentsu Creative Impact, the agency that last year was in news for winning creative duties for a range of Maruti Suzuki brands, has added another key dimension of marketing to its portfolio – Digital. Dentsu Creative Impact, along with its digital partner agency Isobar India, have been awarded the Maruti Suzuki digital mandate after a multi-agency pitch that was held earlier this year.
The DAN team will now handle digital creative, social and media duties for Maruti Suzuki corporate and all model brands other than the Nexa portfolio. A team comprising the best of specialists across digital verticals has been put together to handle this massive mandate.
Speaking on the development, Maruti Suzuki India marketing – VP Sanjeev Handa said, “Our partnership with Dentsu Aegis Network on Digital Mandate is a strategic one. We wanted to have an integrated and synergistic approach to our digital mandate also. We feel having Dentsu Aegis Network as our creative partners in offline, the idea is to have a coherent communication to be more productive and efficient.”
Speaking on the win Dentsu Creative Impact, president Amit Wadhwa said, “It’s great to see that our partnership with Maruti Suzuki is going from strength to strength. What is even more heartening is to see that a leader like Maruti Suzuki is truly looking at an integrated approach. In today’s day and age a uniform approach is what is going to deliver in the market place and when brands like Maruti Suzuki demonstrate it, it forms a great example for others to follow. Look forward to an interesting journey ahead.”
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
